Alpha-amylase variants and polynucleotides encoding same

Patent metadata

Field	Value
Publication number	US-11072786-B2
Application number	US-201515302062-A
Country	US
Kind code	B2
Filing date	Apr 10, 2015
Priority date	Apr 10, 2014
Publication date	Jul 27, 2021
Grant date	Jul 27, 2021

Abstract

The present invention relates to alpha-amylase variants with improved stability in the presence of glucose and/or relatively higher activity on long chain versus short chain substrates. The present encoding invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

First claim

The invention claimed is:

1. An alpha-amylase variant of a parent alpha-amylase comprising a first substitution 201Y and one or more second substitutions of a lysine residue at one or more positions selected from the group consisting of 237, and 392; wherein
(a) the variant has at least 95% and less than 100% sequence identity to SEQ ID NO: 14:
(b) the one or more second substitutions are 237R, and 392V;
(c) each position corresponds to SEQ ID NO: 1; and
(d) the variant has alpha-amylase activity.

2. The alpha-amylase variant of claim 1 , which further comprises 154S.

3. The alpha-amylase variant of claim 1 , which comprises 201Y and 237R.

4. The alpha-amylase variant of claim 1 , which further comprises 315M.

5. The alpha-amylase variant of claim 1 , which comprises 201Y and 392V.

6. The alpha-amylase variant of claim 1 , further comprising one or more third substitutions at one or more positions selected from the group consisting of 68, 133, 136, 142, 154 156, 158, 170, 176, 185, 205, 213, 234, 251, 315, 316, 318, 319, 360, 416 and 437.

7. The alpha-amylase variant of claim 6 , wherein the one or more third substitutions are 68W, 133Y, 136R, 142Y, 154S, 156W, 158W, 170R,S, 176L, 185P, 205Y, 213T, 234T, 251Q, 315W, 316W, 318W, 319Q,L, 360S, 416V, and 437W.

8. A detergent composition comprising an alpha-amylase variant of claim 1 and a surfactant.

9. An isolated polynucleotide encoding the alpha-amylase variant of claim 1 .

10. A nucleic acid construct or expression vector comprising the polynucleotide of claim 9 .

11. A host cell comprising the polynucleotide of claim 9 .

12. A method of producing an alpha-amylase variant, comprising:
(a) cultivating the host cell of claim 11 under conditions suitable for expression of the alpha-amylase variant; and
(b) recovering the alpha-amylase variant.

13. A process of producing a liquefied mash, comprising liquefying a starch-containing material with the alpha-amylase variant of claim 1 to produce a liquefied mash.

14. A process of producing fermentable sugars, comprising
(a) liquefying a starch-containing material with the alpha-amylase variant of claim 1 to produce a liquefied mash; and
(b) saccharifying the liquefied mash to produce fermentable sugars.

15. A process of producing a fermentation product, comprising
(a) liquefying a starch-containing material with the alpha-amylase variant of claim 1 to produce a liquefied mash;
(b) saccharifying the liquefied mash to produce fermentable sugars; and
(c) fermenting the fermentable sugars in the presence of a fermenting organism.

Assignees

• Novozymes As

Inventors

• Andersen Carsten
• Saunders Paria

Classifications

• D06L1/14

  De-sizing · CPC title

• C12N9/2417 Primary

  from microbiological source · CPC title

• C11D3/386

  Preparations containing enzymes {, e.g. protease or amylase} · CPC title

• C12P7/00

  Preparation of oxygen-containing organic compounds · CPC title

• C12C5/004

  Enzymes · CPC title